retatrutide dosing for weight loss A Clinician's Guide to Unapproved weight loss drug retatrutide

With the right tools, education, and support, clinicians can help patients achieve sustainable improvements in both weight and glycemic outcomes

Phytotherapy Research, 34 (3), 448463

Red Flags When Evaluating a Peptide Vendor The FDA's 2025 and 2026 enforcement actions targeted suppliers whose labeling or website language implied human use, suggested therapeutic effects, or marketed the compound by comparison to FDA-approved drugs

Eating slowly ensures less air intake, reducing gas and subsequent sulfur burps

Real needle-free GLP-1 exists: the Wegovy oral tablet (oral semaglutide 25 mg, FDA-approved December 2025, 13.6% weight loss in the OASIS 4 trial) and experimental microneedle patches from Daewoong Therapeutics (80% bioavailability in a 70-person Phase 1 study, 2028-2030 market estimate)